Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
15,950,595
-
Shares change
-
-458,607
-
Total reported value, excl. options
-
$149,089,208
-
Value change
-
-$19,126,895
-
Number of buys
-
42
-
Number of sells
-
-38
-
Price
-
$9.35
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q1 2016
98 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q1 2016.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,950,595 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,865,647 shares), JPMORGAN CHASE & CO (2,438,169 shares), FMR LLC (1,235,000 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,141,436 shares), VANGUARD GROUP INC (687,239 shares), FRANKLIN RESOURCES INC (686,500 shares), First Eagle Investment Management, LLC (588,207 shares), BlackRock Fund Advisors (557,813 shares), QVT Financial LP (507,939 shares), and MORGAN STANLEY (413,672 shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.